These findings were confirmed when Mentis et al. investigated whether GIP could potentiate the insulinotropic or glucagonostatic effects of GLP-1 in type 2 diabetes without concomitant glucose infusion [107]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.